Skip to content

Clinical trials

Completed Dyslipidemias trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Completed Country / region: South Korea Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20081
20114
20121
20132
20146
20157
20168
20178
20186
20199
20205
20219
20228
20233
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical33
Yonsei University6
Daewoong Pharmaceutical Co. LTD.5
Yuhan Corporation5
AstraZeneca4
Boryung Pharmaceutical Co., Ltd4
Hanmi Pharmaceutical Company Limited4
JW Pharmaceutical4
Seoul National University Hospital3
AJU Pharm Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias88
Hypertension36
Diabetes Mellitus, Type 27
Hypercholesterolemia7
Diabetes Mellitus4
Essential Hypertension3
Atherosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Endocrine System Diseases1

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.